More to come! Stay tuned!

So true! And with ML, it’s so hard to comprehend just how quickly the impossible is becoming possible right now.

compute time for many algorithms for protein structure increases quadratically with protein size, which has limited scalability generate bio borrowed a 25 year old trick from astrophysics for simulating the N-body problem to reduce computational complexity read widely!

For #JPM23, I’m turning my Twitter into “Biotech TV.” Will be recording discussions with a ton of top newsmakers and industry leaders. Can’t wait to see many of you IRL and hope those who aren’t able to be in SF enjoy some of the content.🧬📺

Our own Molly Gibson and Jason Silvers attended today's Nasdaq opening bell ringing to celebrate the start of the 41st Annual J.P. Morgan Healthcare Conference. Watch the live broadcast: ow.ly/LLwh50MlJ3a #TeamGenerate #JPM23

In his annual letter, our Co-founder, Noubar Afeyan, shares how we are now turning biological problems into digital problems, and how #AI is being used to generate novel proteins for therapeutic benefit - recently only an imagined future. That future is here. #FlagshipFounded

So grateful to have had Frances Arnold as a supporter and BOD member of our technology and mission of Generate:Biomedicines from the beginning. It's been a fun journey!

Congratulations to the team Generate:Biomedicines ! It's time to bring #GenerativeAI to the field of oncology and there couldn't be a better partner than MD Anderson Cancer Center.

We had so much fun at Generate:Biomedicines bring your child to work day! Thank you to all of the Generators who planned and executed such a thoughtful and entertaining event for our families. #TeamGenerate

Today we announced that we raised $273 million in Series C financing to advance our preclinical & clinical pipeline. We’re proud to have the confidence of our investors, including all Series B investors, who believe we are revolutionizing drug development: bit.ly/3rffQ0q

Today we release Chroma, our generative model for protein design, open-source on Github with a Nature publication describing its biophysical and crystallographic validation. Chroma Conditioners enable one model to target multiple protein design objectives. generatebiomedicines.com/chroma

A monumental work by John Ingraham and team Generate:Biomedicines on Chroma✨ for protein design. Congrats!!! 🔥🎉🔥🎉 So excited to see it out, fully open source and with experimentally validated xtal structures! Perhaps cryo-EM of the giant complexes next? generatebiomedicines.com/chroma

Congratulations Generate:Biomedicines! This is an exciting moment to share a glimpse of the amazing science being done by the team from the foundations of Chroma to testing and learning in the lab - and ultimately developing novel medicines. Just look at those beautiful proteins!

I’ve got binders full of women.

Those are some beautiful proteins Generate:Biomedicines !

This year, Flagship Pioneering and our companies took #BiggerLeaps to pioneer advances to help patients and the planet. Looking forward to what’s ahead in 2024. #WeAreFlagship

We’re thrilled to be featured in this week’s episode of 60 Minutes on CBS, which explores @NVIDIA’s pioneering role in AI and our mutual commitment to transforming human health. Tune in to discover how AI is revolutionizing drug development and more. youtube.com/watch?v=vE8Rw0…

Researchers are using AI to create new proteins that do not exist in nature to fight diseases like cancer and asthma. cbsn.ws/3Qp03FL

We’re thrilled to have been named to the 2024 CNBC Disruptors 50 list, ranking at #25. Alongside OpenAI & ElevateBio, we are proud to be recognized for our pioneering efforts in shaping the future of medicine. Learn more about our recognition: cnbc.com/2024/05/14/gen…

So grateful that Andrew Beam decided to take this crazy leap to team up again to transform all aspects of how we do science with AI! Building companies with big missions is never a straight line- there will be ups, there will be downs- and it’s all about the people by your